Miller Studies Prostate Cancer Awareness and Screening Options Among Minority Men

Prostate cancer is the second leading cause of cancer death in men in the United States.  It is estimated that 26,120 deaths from this disease will occur this year.  Although the number of deaths from prostate cancer continues to decline among all men, the death rate remains more than twice as high in Black men than in any other group.

David B. Miller, PhD, Associate Professor, is examining the awareness and knowledge of prostate cancer and related screening options among minority men (Black and Hispanic/Latino); their risk-perceptions for developing prostate cancer; their involvement in the decision-making process pertaining to treatment options; and perception of provider respect on screening and treatment participation.

This study will sample men living in urban and rural settings. The majority of health disparities research focuses on individuals residing in urban locations thus contributing to a dearth of knowledge related to the health status of men in areas where healthcare providers and services may be limited. Additionally, this study will include minority middle- and upper socioeconomic class men, another group for which researchers have inadequately targeted in health research.

Through the findings of this study, we hope to identify gaps in the awareness and knowledge these men have regarding prostate cancer screening and treatment, differences between men living in urban and rural areas, along with identifying how provider actions influence (or dissuade from) participating in potentially life-saving screening and treatment approaches.